Table:
Targeted Molecular Pathway	Therapy
Improve sarcolemmal strength, dystrophin expression	Omega-3 FTY720 Utrophin upregulation Exon skipping Cell based
Decrease inflammation	Corticosteroids NF-κb inhibition TGFβ inhibition Antioxidants
Improve mitochondrial function	AICAR Metformin Exercise Antioxidants
Decrease fibrosis	Losartan TGFβ inhibition
Improve satellite cell functions	Cell based

Parse the following content of the picture in markdown code: | Targeted Molecular Pathway | Therapy | 
 | --- | ---

| 
 | Improve sarcolemmal strength, dystrophin expression | Omega-3 FTY720 Utrophin upregulation Exon skipping Cell based | 
 | Decrease inflammation | Corticosteroids NF-κb inhibition TGFβ inhibition Antioxidants | 
 | Improve mitochondrial function | AICAR Metformin Exercise Antioxidants | 
 | Decrease fibrosis | Losartan TGFβ inhibition | 
 | Improve satellite cell functions | Cell based |